SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AVXT RESEARCH THREAD
An SI Board Since December 1999
Posts SubjectMarks Bans
35 5 0
Emcee:  chirodoc Type:  Unmoderated
Introduction Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10 COMMERCIALIZATION IN THE NETHERLANDS, GERMANY AND JAPAN Company Exploring Strachirodoc-12/31/1999
9 AVAX RECEIVES ORPHAN DRUG STATUS FOR ITS M-VAX? CANCER VACCINE KANSAS CITY, MIchirodoc-12/31/1999
8 AVAX cancer vaccine receives technology of the year award in bioscience from Schirodoc-12/31/1999
7 OTHER PRODUCTS Topoisomerase Inhibitors: The Company has licensed from Rutgerschirodoc-12/31/1999
6 GOOD OVERVIEW AVAX has licensed from Thomas Jefferson University (TJU) an issuchirodoc-12/31/1999
5 Bullish...EQUATION/CALC DONE part 1by: granmapatty 12/27/1999 1:42 am ESTMsg: chirodoc-12/31/1999
4 AVAX Cancer Vaccine Shrinks Tumors, Prolongs Life, in Study Reported at Key US chirodoc-12/30/1999
3 COMPANY WEBSITE avax-tech.comchirodoc-12/30/1999
2 YAHOO PROFILE biz.yahoo.comchirodoc-12/30/1999
1 AVAX Reports On Initial Results For Potential Ovarian Cancer Vaccine; The Firstchirodoc-12/30/1999
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News